Concepedia

Ronda Rippley

RR

Statistics

Publications

14

Citations

336

H-Index

12

Active since

1995

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Constellation Pharmaceuticals (United States)

Regeneron (United States)

Hackensack University Medical Center

Ronda Rippley is an author at United States Military Academy specializing in pharmacology, pharmacokinetics, and pharmacy.

ORCID

Publications per year

1995–2024

14

Publications

14

The Pharmacokinetics of Enalapril in Children and Infants with Hypertension

Thomas G. Wells, Ronda Rippley, Ronald J. Hogg et al. · The Journal of Clinical Pharmacology · 2001 · 57 citations

, , +15

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma

Kristie A. Blum, Jeffrey G. Supko, Michael B. Maris et al. · Cancer Research Communications · 2022 · 36 citations · Full text

, , +13

A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension

Ronald J. Hogg, Ángela Delucchi, Graciela Sakihara et al. · Pediatric Nephrology · 2007 · 31 citations

, , +12

Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignancies

Feng Yang, Anne Paccaly, Ronda Rippley et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2021 · 28 citations · Full text

, , +16

Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of <i>ARID1A</i> Mutant Cancers

Patricia J. Keller, Elizabeth J. Adams, Rentian Wu et al. · Cancer Research · 2024 · 28 citations · Full text

, , +7

1–5 of 14